CSF biomarkers of Alzheimer disease: “Noncognitive” outcomes

OBJECTIVES: To test whether CSF Alzheimer disease biomarkers (β-amyloid 42 [Aβ(42)], tau, phosphorylated tau at threonine 181 [ptau(181)], tau/Aβ(42), and ptau(181)/Aβ(42)) predict future decline in noncognitive outcomes among individuals cognitively normal at baseline. METHODS: Longitudinal data fr...

Full description

Saved in:
Bibliographic Details
Main Authors: Roe, Catherine M., Fagan, Anne M., Grant, Elizabeth A., Holtzman, David M., Morris, John C.
Format: Artigo
Language:Inglês
Published: Lippincott Williams & Wilkins 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854826/
https://ncbi.nlm.nih.gov/pubmed/24212387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/01.wnl.0000436940.78152.05
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items